DNAprint Genomics (DNAG)

[SlopsterSlasher]

The specific objectives of this proposed collection is to establish a freely-shared case-control collection of DNA samples as a resource for studying genetic predictors of adverse drug reactions. Identifying genetic variants that influence susceptibility to adverse reactions will advance understanding of the molecular basis of adverse drug reactions and may also lead to the development of tests that can predict individual susceptibility to adverse reactions, with obvious benefits to human health. This study has received infrastructure funding for 3 years (starting Jan 03) from the EC 5th Framework Quality of Life Program